OTTAWA, Ontario--(BUSINESS WIRE)--BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback